Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micromeritics Instrument Corporation is a leading global provider of high-performance systems for characterizing particles, powders, and porous materials. The company's technology is critical for pharmaceutical development, where it is used to analyze the surface area, porosity, and density of active pharmaceutical ingredients (APIs) and excipients to ensure stability and bioavailability. Their portfolio includes advanced gas adsorption analyzers, pycnometers, and powder rheology instruments following the acquisition of Freeman Technology. Micromeritics also offers contract analytical services through its Micromeritics Analytical Services (MAS) division. In 2024, the company was acquired by Spectris plc to enhance its scientific sensing and analysis capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Micromeritics Instrument.